Completed
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
NCT00941863
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- Philadelphia, Pennsylvania, United States
- Nashville, Tennessee, United States
- Madison, Wisconsin, United States